Cantor Fitzgerald Reiterates Overweight on Asensus Surgical, Maintains $1 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Asensus Surgical (AMEX:ASXC) and maintained a $1 price target.
August 22, 2023 | 2:37 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Asensus Surgical's stock rating has been reiterated as Overweight by Cantor Fitzgerald, with a maintained price target of $1.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Asensus Surgical. However, as the price target is maintained at $1, it suggests that the analyst does not foresee significant short-term price movement. Therefore, the impact on the stock price is neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100